Epilepsy is one of the most common chronic neurological diseases, affecting more than 50 million people worldwide. Although it is believed that a large proportion of childhood-onset epilepsies are caused by genetic changes, it remains unknown precisely how many of these patients suffer from a genetic disorder and how often the treatment can be targeted […]
September 01, 2021 | Epilepsy, News, Research, Treatment
Epilepsy is a brain disorder that arises from imbalances of brain chemicals called neurotransmitters. This disorder manifests as recurring seizure, unconsciousness and momentary loss of memory. These events are frequent and unpredictable. This is because the brain cells called neurons either overwork or are unable to balance the release of two chemicals that are vital for […]
September 01, 2021 | News, Research, Treatment
Key Takeaways Vagus Nerve Stimulation (VNS) Therapy does not require brain surgery.1 You may need to keep taking antiepileptic drugs along with VNS Therapy.1 The benefits of VNS Therapy usually improve over time.2 VNS Therapy can be controlled both automatically and manually.3 If you want to stop using VNS Therapy, it can be turned off […]
August 04, 2021 | Featured Slider, Treatment
The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed. For the study, published in Brain Communications, clinicians evaluated the use of K.Vita®, (also known as Betashot), an oral liquid dietary supplement developed by […]
July 23, 2021 | Ketogenic Diet, News, Treatment
Indiana University School of Medicine researchers are developing a new, noninvasive brain stimulation technique to treat neurological disorders, including pain, traumatic brain injury (TBI), epilepsy, Parkinson’s disease, Alzheimer’s disease and more. “Given the increasing use of brain stimulation in human brain study and treatment of neurological diseases, this research can make a big impact on […]
July 02, 2021 | Neurology, News, Research, Technology, Treatment
Brain stimulation tech developer Neuroelectrics announced today that it’s secured FDA breakthrough device designation for its Starstim neuromodulation platform to treat refractory focal epilepsy. Starstim includes transcranial electrical stimulation (tES), personalized treatment protocols and a secure cloud-based mechanism to deliver treatment anywhere. “We are excited to receive the FDA Breakthrough Device Designation for our lead […]
July 01, 2021 | Neurology, Research, Technology, Treatment